BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 25808097)

  • 21. Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines.
    Kausar T; Ahsan A; Hasan MR; Lin L; Beer DG; Ralhan R
    Int J Cancer; 2010 Mar; 126(6):1494-503. PubMed ID: 19685492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
    Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of photodynamic therapy on the Warburg effect in esophageal cancer cells.
    Gan J; Li S; Meng Y; Liao Y; Jiang M; Qi L; Li Y; Bai Y
    Lasers Med Sci; 2020 Oct; 35(8):1741-1750. PubMed ID: 32034563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
    Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
    Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
    Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.
    Yan J; Zhang D; Han Y; Wang Z; Ma C
    J Cell Biochem; 2019 Oct; 120(10):17303-17311. PubMed ID: 31106485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
    Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
    Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
    Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer.
    Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X
    Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
    de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
    Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
    Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y
    Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.
    Boschert V; Teusch J; Müller-Richter UDA; Brands RC; Hartmann S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.